During an experimental study, an investigator develops a new member of the class of non-nucleoside reverse transcriptase inhibitors. This new drug most likely inhibits HIV infection through which of the following mechanisms? Binding to reverse transcriptase Binding to RNase H Blockade of integration Incorporation into viral DNA Phosphorylation of nucleoside trisphosphates
000000 Visualizações
|
0 Curtidas
During an experimental study, an investigator develops a new member of the class of non-nucleoside reverse transcriptase inhibitors. This new drug most likely inhibits HIV infection through which of the following mechanisms?
Binding to reverse transcriptase
Binding to RNase H
Blockade of integration
Incorporation into viral DNA
Phosphorylation of nucleoside trisphosphates